It will simply mislead people about what they’ll truly pay for their medicines.
“Knowing what something costs before buying it is just common sense.” That’s how Sen. Chuck Grassley, R-Iowa, justified a bill he introduced in January to require drug companies to include a medicine’s list price in their advertisements.
Unfortunately, his Drug-price Transparency for Consumers, or DTC, Act — co-sponsored by Sen. Dick Durbin, D-Ill. — would only make drug prices more confusing for consumers.
And it would draw attention away from the middlemen in the drug supply chain who are responsible for escalating costs at the pharmacy.
Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.
Congress Eyes Regulating Drug Ads, It Won’t Mean Lower Prices
Sally C. Pipes
The DTC Act won’t bring down drug prices.
It will simply mislead people about what they’ll truly pay for their medicines.
“Knowing what something costs before buying it is just common sense.” That’s how Sen. Chuck Grassley, R-Iowa, justified a bill he introduced in January to require drug companies to include a medicine’s list price in their advertisements.
Unfortunately, his Drug-price Transparency for Consumers, or DTC, Act — co-sponsored by Sen. Dick Durbin, D-Ill. — would only make drug prices more confusing for consumers.
And it would draw attention away from the middlemen in the drug supply chain who are responsible for escalating costs at the pharmacy.
Read the op-ed here.
Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.